Australia Is Latest Country to Say ‘No’ to Leqembi
Eisai and Biogen’s Alzheimer’s drug Leqembi (generic name lecanemab) was the first fully-FDA approved disease-modifying treatment for early-stage Alzheimer’s disease in United States history,…
Eisai and Biogen’s Alzheimer’s drug Leqembi (generic name lecanemab) was the first fully-FDA approved disease-modifying treatment for early-stage Alzheimer’s disease in United States history,…
Can a seemingly harmless virus in the gut wreak havoc on the brain decades after the initial infection? And could catching and treating an…
Blood tests provide great snapshots of a person’s health status. Medical providers regularly use them to assess a person’s risk of chronic diseases. High…
You’ve likely encountered Red Dye #3 before. It’s a common additive to many candies, beverages, baked goods, cereals, maraschino cherries and gelatin desserts, as…
As dementia rates rise globally, families and care partners are seeking ways to maintain meaningful connections with loved ones experiencing memory loss. In many…
There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of Alzheimer’s disease, these are both costly…
Roughly a quarter of all Americans over the age of 40 in the U.S. take statin drugs — which lower levels of cholesterol —…
Less red meat is good for the planet and a growing number of people have started the new year resolving to pursue a meat-free…
Fourteen years ago, lawyer Sonia Vallabh took a genetic test that showed she would one day contract a fatal disease that ends in a…
Racism steals time from people’s lives – possibly because of the space it occupies in the mind. In a new study published in the…
Everyday physical activity, like going for a short walk or playing with the kids, may provide short-term benefits for cognitive health, equivalent to reversing…
In 1907, a Belgian chemist named Leo Baekelend developed a revolutionary new material that would soon become a hallmark of the modern era: fully…
In the brains of people with Alzheimer’s diseases, problematic proteins called beta-amyloid build up and clump together in plaques, harming and eventually killing off…
Brain Talk, hosted by Being Patient founder Deborah Kan and journalist Mark Niu, digs into the topics that matter most to the Being Patient…
Some 2.3 million of U.S. adults over 65 – more than 4 percent – have a diagnosis of dementia. But even without a diagnosis,…